Status:
TERMINATED
Nabilone in Cannabis Users With PTSD
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cannabis
Post Traumatic Stress Disorder
Eligibility:
All Genders
21-45 years
Phase:
PHASE1
PHASE2
Brief Summary
Despite the prevalence of cannabis use among the PTSD population and self-reports that it is used to help cope with PTSD symptoms, the direct effects of cannabis on PTSD symptomology are unknown. The ...
Detailed Description
This study will compare the effects of smoked cannabis and nabilone on attentional bias toward trauma- related stimuli, subjective and emotional processing to a range of trauma-and non-trauma-related ...
Eligibility Criteria
Inclusion
- Current cannabis use
- PTSD symptoms
- Able to give informed consent and comply with study procedures
- Women who are normally cycling and practicing an effective form of birth control other than hormonal contraceptives
Exclusion
- Meeting criteria for certain current psychiatric disorders
- Clinical laboratory tests outside of normal limits
- History of clinically significant cardiac or respiratory diagnoses
- Current parole or probation
- Women who are currently pregnant or breastfeeding
Key Trial Info
Start Date :
October 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03251326
Start Date
October 1 2015
End Date
June 1 2019
Last Update
July 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032